Coronary plaque vulnerability in metabolic syndrome - Assessment of carotid artery morphology in acute coronary syndrome

Circulation Journal

Volumn 71, Issue 8, 2007, Pages 1229-1233

  Kato, Masaya ^a   Dote, Keigo ^a   Sasaki, Shota ^a   Ueda, Kentaro ^a   Matsuda, Osamu ^a   Nakano, Yoshinori ^a   Naganuma, Toru ^a   Sugiura, Tomohito ^a  

^a HIROSHIMA CITY ASA HOSPITAL   (Japan)

Author keywords

Carotid arteries; Coronary artery disease; Metabolic syndrome; Vascular remodeling

Indexed keywords

HIGH DENSITY LIPOPROTEIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY INTIMA; ARTICLE; ATHEROSCLEROTIC PLAQUE; B SCAN; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY;

ACUTE DISEASE; AGED; CAROTID ARTERIES; CORONARY ANGIOGRAPHY; CORONARY DISEASE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; RISK FACTORS;

EID: 34547560190     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.1229     Document Type: Article

References (24)

1. National Cholesterol Education Program. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001; 285: 2486-2497.
2. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
3. Meigs JB, D'Agostino RB Sr, Wilson PW, Cupples LA, Nathan DM, Singer DE. Risk variable clustering in the insulin resistance syndrome: The Framingham Offspring Study. Diabetes 1997; 46: 1594-1600.
4. Klein BE, Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in beaver dam. Diabetes Care 2002; 25: 1790-1794.
5. Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2004; 109: 42-46.
6. Poli A, Tremoli E, Colombo A, Sirtori M, Pignoli P, Paoletti R. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients: A new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects. Atherosclerosis 1988; 70: 253-261.
7. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999; 340: 14-22.
8. Kato M, Dote K, Habara S, Takemoto H, Goto K, Nakaoka K. Clinical implications of carotid artery remodeling in acute coronary syndrome: Ultrasonographic assessment of positive remodeling. J Am Coll Cardiol 2003; 42: 1026-1032.
9. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004; 292: 2237-2242.
10. Ishikawa S, Kayaba K, Gotoh T, Nakamura Y, Kajii E. Metabolic syndrome and C-reactive protein in the general population: JMS Cohort Study. Circ J 2007; 71: 26-31.
11. The Examination Committee of Criteria for Metabolic Syndrome. Definition and criteria of metabolic syndrome. J Jpn Soc Int Med 2005; 94: 794-809.
12. Kato M, Shiode N, Yamagata T, Matsuura H, Kajiyama G. Coronary segmental responses to acetylcholine and bradykinin in patients with atherosclerotic risk factors. Am J Cardiol 1997; 80: 751-755.
13. Ambrose JA, Winters SL, Stern A, Eng A, Teichhotz LE, Gorlin R, et al. Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol 1985; 5: 609-616.
14. Rehr R, Disciascio G, Vetrovec G, Cowley M. Angiographic morphology of coronary artery stenoses in prolonged rest angina: Evidence of intracoronary thrombosis. J Am Coll Cardiol 1989; 14: 1429-1437.
15. Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O'Neill WW. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000; 343: 915-922.
16. Lee SG, Lee CW, Hong MK, Kim JJ, Park SW, Park SJ. Change of multiple complex coronary plaques in patients with acute myocardial infarction: A study with coronary angiography. Am Heart J 2004; 147: 281-286.
17. Goldstein JA, Chandra HR, O'Neill WW. Relation of number of complex coronary lesions to serum C-reactive protein levels and major adverse cardiovascular events at one year. Am J Cardiol 2005; 96: 56-60.
18. Olsson AG, Schwartz GG, Szarek M, Sasiela WJ, Ezekowitz MD, Ganz P, et al. High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: Results from the MIRACL trial. Eur Heart J 2005; 26: 890-896.
19. Pyorala K, Ballantyne CM, Gumbiner B, Lee MW, Shah A, Davies MJ, et al for the Scandinavian Simvastatin Survival Study (4S). Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: Subgroup analyses of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 2004; 27: 1735-1740.
20. Schwartz GG, Olsson AG, Szarek M, Sasiela WJ. Relation of characteristics of metabolic syndrome to short-term prognosis and effects of intensive statin therapy after acute coronary syndrome: An analysis of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) trial. Diabetes Care 2005; 28: 2508-2513.
21. Schoenhagen P, Tuzcu EM, Apperson-Hansen C, Wang C, Wolski K, Lin S, et al. Determinants of arterial wall remodeling during lipid-lowering therapy: Serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial. Circulation 2006; 113: 2826-2834.
22. Tsimikas S, Willerson JT, Ridker PM. C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J Am Coll Cardiol 2006; 47(Suppl 8): C19-C31.
23. Oda E, Watanabe K. Japanese criteria of metabolic syndrome. Circ J 2006; 70: 364.
24. Oizumi T, Daimon M, Wada K, Jimbu Y, Kameda W, Susa S, et al. A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population. Circ J 2006; 70: 1663.